Comorbidities increase COVID‐19 hospitalization in young people with type 1 diabetes

OBJECTIVES: We evaluated COVID‐19 outcomes in children and young adults with type 1 diabetes (T1D) to determine if those with comorbidities are more likely to experience severe COVID‐19 compared to those without. RESEARCH DESIGN AND METHODS: This cross‐sectional study included questionnaire data on patients <25 years of age with established T1D and laboratory‐confirmed COVID‐19 from 52 sites across the US between April 2020 and October 2021. We examined patient factors and COVID‐19 outcomes between those with and without comorbidities. Multivariate logistic regression analysis examined the odds of hospitalization among groups, adjusting for age, HbA1c, race and ethnicity, insurance type and duration of diabetes. RESULTS: Six hundred fifty‐one individuals with T1D and COVID‐19 were analyzed with mean age 15.8 (SD 4.1) years. At least one comorbidity was present in 31%, and more than one in 10%. Obesity and asthma were the most frequently reported comorbidities, present in 19% and 17%, respectively. Hospitalization occurred in 17% of patients and 52% of hospitalized patients required ICU level care. Patients with at least one comorbidity were almost twice as likely to be hospitalized with COVID‐19 than patients with no comorbidities (Odds ratio 2.0, 95% CI: 1.3–3.1). This relationship persisted after adjusting for age, HbA1c, race and ethnicity (minority vs nonminority), insurance type (public vs. private), and duration of diabetes. CONCLUSIONS: Our findings show that comorbidities increase the risk for hospitalization with COVID‐19 in children and young adults highlighting the need for tailored COVID‐19 prevention and treatment strategies in T1D.